Researchers conducted study to determine whether a microbiota-based investigational live biotherapeutic (RBX2660) decreases the risk for recurrent Clostridioides difficile infection.
Researchers evaluated the association between diarrheagenic E coli and development of reactive arthritis and musculoskeletal symptoms among international travelers.
A subset of patients with coronavirus disease 2019 (COVID-19) may present with low disease severity marked only by digestive symptoms.
There are significant differences in the clinical features of early, late, and alcohol-related idiopathic chronic pancreatitis.
For patients with uncomplicated acute diverticulitis, forgoing antibiotic use did not increase the length of hospital stay.
Patients with HIV and those with a history of intravenous drug use may have significantly higher rates of hepatic steatosis.
The American Society for Gastrointestinal Endoscopy convened a panel to create recommendations for the use of endoscopy in patients with familial adenomatous polyposis syndrome.
A rotavirus vaccination program led to significant and sustained reductions in both hospitalizations and emergency department visits across the US.
Tofacitinib is the first JAK inhibitor approved by the FDA for the treatment of UC in patients whose disease worsened or did not improve with conventional therapy.
Current guidance from the US Preventive Services Task Force recommends against screening patients older than 85 years for colorectal cancer.
